DEREK BOST: Open Payments
NPI 1952406274 · LENOIR, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 45 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $137 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $105 |
| Merck Sharp & Dohme LLC | 5 | $88 |
| Novo Nordisk Inc | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| SCPHARMACEUTICALS INC. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| PFIZER INC. | 2 | $42 |
Products named: REPATHA, LifeVest, ELIQUIS, Wegovy, VERQUVO, LEQVIO, JARDIANCE, FUROSCIX.
Industry payments across NC — which companies pay providers there.
